We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JELD icon
2976
JELD-WEN Holding
JELD
$168M
$31.5K ﹤0.01%
1,798
-91
-5% -$1.27K
GLBE icon
2977
Global E Online
GLBE
$6.87B
$31.5K ﹤0.01%
+770
New +$25.3K
RGNX icon
2978
Regenxbio
RGNX
$704M
$31.4K ﹤0.01%
1,572
-10
-0.6% -$193
ARKQ icon
2979
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.05B
$31.4K ﹤0.01%
+557
New +$27.6K
PFI icon
2980
Invesco Dorsey Wright Financial Momentum ETF
PFI
$59.2M
$31.4K ﹤0.01%
746
-6
-0.8% -$243
MFA
2981
MFA Financial
MFA
$931M
$31.3K ﹤0.01%
2,788
-8,476
-75% -$90.2K
KTOS icon
2982
Kratos Defense & Security Solutions
KTOS
$11.7B
$31.3K ﹤0.01%
2,185
-815
-27% -$11K
KPTI icon
2983
Karyopharm Therapeutics
KPTI
$47.1M
$31.3K ﹤0.01%
1,164
-126
-10% -$5.43K
MBC icon
2984
MasterBrand
MBC
$1.88B
$31.2K ﹤0.01%
2,686
+1,864
+227% +$17.9K
MCHI icon
2985
iShares MSCI China ETF
MCHI
$6.27B
$31.2K ﹤0.01%
698
+312
+81% +$14.6K
AIR icon
2986
AAR Corp
AIR
$5.85B
$31.2K ﹤0.01%
540
-511
-49% -$27.6K
WD icon
2987
Walker & Dunlop
WD
$1.5B
$31.2K ﹤0.01%
394
-688
-64% -$49.7K
IDT icon
2988
IDT Corp
IDT
$1.65B
$31.1K ﹤0.01%
1,204
+539
+81% +$16.6K
IESC icon
2989
IES Holdings
IESC
$15.1B
$31.1K ﹤0.01%
547
+180
+49% +$8.6K
RICK icon
2990
RCI Hospitality Holdings
RICK
$210M
$31.1K ﹤0.01%
409
-2,754
-87% -$207K
ESPR
2991
DELISTED
Esperion Therapeutics
ESPR
$31.1K ﹤0.01%
22,346
+1,439
+7% +$2.01K
CHGG icon
2992
Chegg
CHGG
$93.5M
$31K ﹤0.01%
3,496
+32
+0.9% +$388
KNSA icon
2993
Kiniksa Pharmaceuticals
KNSA
$6.05B
$31K ﹤0.01%
2,202
-2,713
-55% -$36.3K
GOGL
2994
DELISTED
Golden Ocean Group
GOGL
$31K ﹤0.01%
4,106
+1,254
+44% +$10.4K
DDL
2995
Dingdong
DDL
$516M
$31K ﹤0.01%
+10,032
New +$33.4K
CMPR icon
2996
Cimpress
CMPR
$2.34B
$31K ﹤0.01%
521
+51
+11% +$2.51K
LADR
2997
Ladder Capital
LADR
$1.26B
$31K ﹤0.01%
2,856
-8,998
-76% -$87.2K
RKLB icon
2998
Rocket Lab Corp
RKLB
$49.4B
$31K ﹤0.01%
5,163
-4,851
-48% -$22.3K
VERA icon
2999
Vera Therapeutics
VERA
$2.17B
$30.9K ﹤0.01%
1,928
-2,906
-60% -$26.2K
VERY
3000
DELISTED
Vericity, Inc. Common Stock
VERY
$30.9K ﹤0.01%
5,131
+3,156
+160% +$21.4K

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.